Sofosbuvir (CAS 1190307-88-0) Market, Global Outlook and Forecast 2022-2028
The report is about Sofosbuvir API market.
This report contains market size and forecasts of Sofosbuvir (CAS 1190307-88-0) in global, including the following market information:
Global Sofosbuvir (CAS 1190307-88-0) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sofosbuvir (CAS 1190307-88-0) Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Sofosbuvir (CAS 1190307-88-0) companies in 2021 (%)
The global Sofosbuvir (CAS 1190307-88-0) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity ? 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sofosbuvir (CAS 1190307-88-0) include Teva Pharmaceutical Industries Ltd, DONG BANG FUTURE TECH & LIFE CO., LTD, Beaukev Pharma International Pvt.Ltd, DEAFARMA, Tecoland, Anhui HaiKang Pharmaceutical Co. Ltd, Shanghai Haoyuan Chemexpress Co., Ltd, Beijing Kawin Technology Share-holding Co and Hangzhou Longshine Bio-Tech Co. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sofosbuvir (CAS 1190307-88-0) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sofosbuvir (CAS 1190307-88-0) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Sofosbuvir (CAS 1190307-88-0) Market Segment Percentages, by Type, 2021 (%)
Global Sofosbuvir (CAS 1190307-88-0) Market Segment Percentages, by Application, 2021 (%)
Global Sofosbuvir (CAS 1190307-88-0) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Sofosbuvir (CAS 1190307-88-0) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sofosbuvir (CAS 1190307-88-0) revenues share in global market, 2021 (%)
Key companies Sofosbuvir (CAS 1190307-88-0) sales in global market, 2017-2022 (Estimated), (MT)
Key companies Sofosbuvir (CAS 1190307-88-0) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Sofosbuvir (CAS 1190307-88-0) in global, including the following market information:
Global Sofosbuvir (CAS 1190307-88-0) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sofosbuvir (CAS 1190307-88-0) Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Sofosbuvir (CAS 1190307-88-0) companies in 2021 (%)
The global Sofosbuvir (CAS 1190307-88-0) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity ? 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sofosbuvir (CAS 1190307-88-0) include Teva Pharmaceutical Industries Ltd, DONG BANG FUTURE TECH & LIFE CO., LTD, Beaukev Pharma International Pvt.Ltd, DEAFARMA, Tecoland, Anhui HaiKang Pharmaceutical Co. Ltd, Shanghai Haoyuan Chemexpress Co., Ltd, Beijing Kawin Technology Share-holding Co and Hangzhou Longshine Bio-Tech Co. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sofosbuvir (CAS 1190307-88-0) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sofosbuvir (CAS 1190307-88-0) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Sofosbuvir (CAS 1190307-88-0) Market Segment Percentages, by Type, 2021 (%)
- Purity ? 98%
- Purity ? 98%
Global Sofosbuvir (CAS 1190307-88-0) Market Segment Percentages, by Application, 2021 (%)
- Adults Patients
- Elderly Patients
Global Sofosbuvir (CAS 1190307-88-0) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Sofosbuvir (CAS 1190307-88-0) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sofosbuvir (CAS 1190307-88-0) revenues share in global market, 2021 (%)
Key companies Sofosbuvir (CAS 1190307-88-0) sales in global market, 2017-2022 (Estimated), (MT)
Key companies Sofosbuvir (CAS 1190307-88-0) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Teva Pharmaceutical Industries Ltd
- DONG BANG FUTURE TECH & LIFE CO., LTD
- Beaukev Pharma International Pvt.Ltd
- DEAFARMA
- Tecoland
- Anhui HaiKang Pharmaceutical Co. Ltd
- Shanghai Haoyuan Chemexpress Co., Ltd
- Beijing Kawin Technology Share-holding Co
- Hangzhou Longshine Bio-Tech Co
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Sofosbuvir (CAS 1190307-88-0) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sofosbuvir (CAS 1190307-88-0) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SOFOSBUVIR (CAS 1190307-88-0) OVERALL MARKET SIZE
2.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size: 2021 VS 2028
2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Sofosbuvir (CAS 1190307-88-0) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Sofosbuvir (CAS 1190307-88-0) Players in Global Market
3.2 Top Global Sofosbuvir (CAS 1190307-88-0) Companies Ranked by Revenue
3.3 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Companies
3.4 Global Sofosbuvir (CAS 1190307-88-0) Sales by Companies
3.5 Global Sofosbuvir (CAS 1190307-88-0) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Sofosbuvir (CAS 1190307-88-0) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sofosbuvir (CAS 1190307-88-0) Players in Global Market
3.8.1 List of Global Tier 1 Sofosbuvir (CAS 1190307-88-0) Companies
3.8.2 List of Global Tier 2 and Tier 3 Sofosbuvir (CAS 1190307-88-0) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Sofosbuvir (CAS 1190307-88-0) Market Size Markets, 2021 & 2028
4.1.2 Purity ? 98%
4.1.3 Purity ? 98%
4.2 By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue & Forecasts
4.2.1 By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2022
4.2.2 By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2023-2028
4.2.3 By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
4.3 By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales & Forecasts
4.3.1 By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2022
4.3.2 By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales, 2023-2028
4.3.3 By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
4.4 By Type - Global Sofosbuvir (CAS 1190307-88-0) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Sofosbuvir (CAS 1190307-88-0) Market Size, 2021 & 2028
5.1.2 Adults Patients
5.1.3 Elderly Patients
5.2 By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue & Forecasts
5.2.1 By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2022
5.2.2 By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2023-2028
5.2.3 By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
5.3 By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales & Forecasts
5.3.1 By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2022
5.3.2 By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales, 2023-2028
5.3.3 By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
5.4 By Application - Global Sofosbuvir (CAS 1190307-88-0) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Sofosbuvir (CAS 1190307-88-0) Market Size, 2021 & 2028
6.2 By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue & Forecasts
6.2.1 By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2022
6.2.2 By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2023-2028
6.2.3 By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
6.3 By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales & Forecasts
6.3.1 By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2022
6.3.2 By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales, 2023-2028
6.3.3 By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2028
6.4.2 By Country - North America Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2028
6.4.3 US Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.4.4 Canada Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.4.5 Mexico Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2028
6.5.2 By Country - Europe Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2028
6.5.3 Germany Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5.4 France Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5.5 U.K. Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5.6 Italy Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5.7 Russia Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5.8 Nordic Countries Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5.9 Benelux Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2028
6.6.2 By Region - Asia Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2028
6.6.3 China Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.6.4 Japan Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.6.5 South Korea Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.6.6 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.6.7 India Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2028
6.7.2 By Country - South America Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2028
6.7.3 Brazil Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.7.4 Argentina Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2028
6.8.3 Turkey Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.8.4 Israel Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.8.5 Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.8.6 UAE Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva Pharmaceutical Industries Ltd
7.1.1 Teva Pharmaceutical Industries Ltd Corporate Summary
7.1.2 Teva Pharmaceutical Industries Ltd Business Overview
7.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.1.4 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.1.5 Teva Pharmaceutical Industries Ltd Key News
7.2 DONG BANG FUTURE TECH & LIFE CO., LTD
7.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Corporate Summary
7.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Business Overview
7.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Key News
7.3 Beaukev Pharma International Pvt.Ltd
7.3.1 Beaukev Pharma International Pvt.Ltd Corporate Summary
7.3.2 Beaukev Pharma International Pvt.Ltd Business Overview
7.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.3.4 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.3.5 Beaukev Pharma International Pvt.Ltd Key News
7.4 DEAFARMA
7.4.1 DEAFARMA Corporate Summary
7.4.2 DEAFARMA Business Overview
7.4.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.4.4 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.4.5 DEAFARMA Key News
7.5 Tecoland
7.5.1 Tecoland Corporate Summary
7.5.2 Tecoland Business Overview
7.5.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.5.4 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.5.5 Tecoland Key News
7.6 Anhui HaiKang Pharmaceutical Co. Ltd
7.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Corporate Summary
7.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Business Overview
7.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.6.5 Anhui HaiKang Pharmaceutical Co. Ltd Key News
7.7 Shanghai Haoyuan Chemexpress Co., Ltd
7.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Corporate Summary
7.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Business Overview
7.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.7.5 Shanghai Haoyuan Chemexpress Co., Ltd Key News
7.8 Beijing Kawin Technology Share-holding Co
7.8.1 Beijing Kawin Technology Share-holding Co Corporate Summary
7.8.2 Beijing Kawin Technology Share-holding Co Business Overview
7.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.8.4 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.8.5 Beijing Kawin Technology Share-holding Co Key News
7.9 Hangzhou Longshine Bio-Tech Co
7.9.1 Hangzhou Longshine Bio-Tech Co Corporate Summary
7.9.2 Hangzhou Longshine Bio-Tech Co Business Overview
7.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.9.4 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.9.5 Hangzhou Longshine Bio-Tech Co Key News
8 GLOBAL SOFOSBUVIR (CAS 1190307-88-0) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity, 2017-2028
8.2 Sofosbuvir (CAS 1190307-88-0) Production Capacity of Key Manufacturers in Global Market
8.3 Global Sofosbuvir (CAS 1190307-88-0) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 SOFOSBUVIR (CAS 1190307-88-0) SUPPLY CHAIN ANALYSIS
10.1 Sofosbuvir (CAS 1190307-88-0) Industry Value Chain
10.2 Sofosbuvir (CAS 1190307-88-0) Upstream Market
10.3 Sofosbuvir (CAS 1190307-88-0) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sofosbuvir (CAS 1190307-88-0) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Sofosbuvir (CAS 1190307-88-0) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sofosbuvir (CAS 1190307-88-0) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SOFOSBUVIR (CAS 1190307-88-0) OVERALL MARKET SIZE
2.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size: 2021 VS 2028
2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Sofosbuvir (CAS 1190307-88-0) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Sofosbuvir (CAS 1190307-88-0) Players in Global Market
3.2 Top Global Sofosbuvir (CAS 1190307-88-0) Companies Ranked by Revenue
3.3 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Companies
3.4 Global Sofosbuvir (CAS 1190307-88-0) Sales by Companies
3.5 Global Sofosbuvir (CAS 1190307-88-0) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Sofosbuvir (CAS 1190307-88-0) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sofosbuvir (CAS 1190307-88-0) Players in Global Market
3.8.1 List of Global Tier 1 Sofosbuvir (CAS 1190307-88-0) Companies
3.8.2 List of Global Tier 2 and Tier 3 Sofosbuvir (CAS 1190307-88-0) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Sofosbuvir (CAS 1190307-88-0) Market Size Markets, 2021 & 2028
4.1.2 Purity ? 98%
4.1.3 Purity ? 98%
4.2 By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue & Forecasts
4.2.1 By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2022
4.2.2 By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2023-2028
4.2.3 By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
4.3 By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales & Forecasts
4.3.1 By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2022
4.3.2 By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales, 2023-2028
4.3.3 By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
4.4 By Type - Global Sofosbuvir (CAS 1190307-88-0) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Sofosbuvir (CAS 1190307-88-0) Market Size, 2021 & 2028
5.1.2 Adults Patients
5.1.3 Elderly Patients
5.2 By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue & Forecasts
5.2.1 By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2022
5.2.2 By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2023-2028
5.2.3 By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
5.3 By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales & Forecasts
5.3.1 By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2022
5.3.2 By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales, 2023-2028
5.3.3 By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
5.4 By Application - Global Sofosbuvir (CAS 1190307-88-0) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Sofosbuvir (CAS 1190307-88-0) Market Size, 2021 & 2028
6.2 By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue & Forecasts
6.2.1 By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2022
6.2.2 By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2023-2028
6.2.3 By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
6.3 By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales & Forecasts
6.3.1 By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2022
6.3.2 By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales, 2023-2028
6.3.3 By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2028
6.4.2 By Country - North America Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2028
6.4.3 US Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.4.4 Canada Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.4.5 Mexico Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2028
6.5.2 By Country - Europe Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2028
6.5.3 Germany Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5.4 France Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5.5 U.K. Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5.6 Italy Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5.7 Russia Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5.8 Nordic Countries Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.5.9 Benelux Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2028
6.6.2 By Region - Asia Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2028
6.6.3 China Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.6.4 Japan Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.6.5 South Korea Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.6.6 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.6.7 India Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2028
6.7.2 By Country - South America Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2028
6.7.3 Brazil Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.7.4 Argentina Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales, 2017-2028
6.8.3 Turkey Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.8.4 Israel Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.8.5 Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
6.8.6 UAE Sofosbuvir (CAS 1190307-88-0) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva Pharmaceutical Industries Ltd
7.1.1 Teva Pharmaceutical Industries Ltd Corporate Summary
7.1.2 Teva Pharmaceutical Industries Ltd Business Overview
7.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.1.4 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.1.5 Teva Pharmaceutical Industries Ltd Key News
7.2 DONG BANG FUTURE TECH & LIFE CO., LTD
7.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Corporate Summary
7.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Business Overview
7.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Key News
7.3 Beaukev Pharma International Pvt.Ltd
7.3.1 Beaukev Pharma International Pvt.Ltd Corporate Summary
7.3.2 Beaukev Pharma International Pvt.Ltd Business Overview
7.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.3.4 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.3.5 Beaukev Pharma International Pvt.Ltd Key News
7.4 DEAFARMA
7.4.1 DEAFARMA Corporate Summary
7.4.2 DEAFARMA Business Overview
7.4.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.4.4 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.4.5 DEAFARMA Key News
7.5 Tecoland
7.5.1 Tecoland Corporate Summary
7.5.2 Tecoland Business Overview
7.5.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.5.4 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.5.5 Tecoland Key News
7.6 Anhui HaiKang Pharmaceutical Co. Ltd
7.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Corporate Summary
7.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Business Overview
7.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.6.5 Anhui HaiKang Pharmaceutical Co. Ltd Key News
7.7 Shanghai Haoyuan Chemexpress Co., Ltd
7.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Corporate Summary
7.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Business Overview
7.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.7.5 Shanghai Haoyuan Chemexpress Co., Ltd Key News
7.8 Beijing Kawin Technology Share-holding Co
7.8.1 Beijing Kawin Technology Share-holding Co Corporate Summary
7.8.2 Beijing Kawin Technology Share-holding Co Business Overview
7.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.8.4 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.8.5 Beijing Kawin Technology Share-holding Co Key News
7.9 Hangzhou Longshine Bio-Tech Co
7.9.1 Hangzhou Longshine Bio-Tech Co Corporate Summary
7.9.2 Hangzhou Longshine Bio-Tech Co Business Overview
7.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Major Product Offerings
7.9.4 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales and Revenue in Global (2017-2022)
7.9.5 Hangzhou Longshine Bio-Tech Co Key News
8 GLOBAL SOFOSBUVIR (CAS 1190307-88-0) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity, 2017-2028
8.2 Sofosbuvir (CAS 1190307-88-0) Production Capacity of Key Manufacturers in Global Market
8.3 Global Sofosbuvir (CAS 1190307-88-0) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 SOFOSBUVIR (CAS 1190307-88-0) SUPPLY CHAIN ANALYSIS
10.1 Sofosbuvir (CAS 1190307-88-0) Industry Value Chain
10.2 Sofosbuvir (CAS 1190307-88-0) Upstream Market
10.3 Sofosbuvir (CAS 1190307-88-0) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sofosbuvir (CAS 1190307-88-0) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Sofosbuvir (CAS 1190307-88-0) in Global Market
Table 2. Top Sofosbuvir (CAS 1190307-88-0) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Companies, 2017-2022
Table 5. Global Sofosbuvir (CAS 1190307-88-0) Sales by Companies, (MT), 2017-2022
Table 6. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Sofosbuvir (CAS 1190307-88-0) Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Type
Table 9. List of Global Tier 1 Sofosbuvir (CAS 1190307-88-0) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sofosbuvir (CAS 1190307-88-0) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales (MT), 2017-2022
Table 15. By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales (MT), 2023-2028
Table 16. By Application – Global Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales (MT), 2017-2022
Table 20. By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales (MT), 2023-2028
Table 21. By Region – Global Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales (MT), 2017-2022
Table 25. By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales (MT), 2023-2028
Table 26. By Country - North America Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2017-2022
Table 29. By Country - North America Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2023-2028
Table 30. By Country - Europe Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2017-2022
Table 33. By Country - Europe Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2023-2028
Table 34. By Region - Asia Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2017-2022
Table 37. By Region - Asia Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2023-2028
Table 38. By Country - South America Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2017-2022
Table 41. By Country - South America Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2023-2028
Table 46. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 47. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 48. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. DONG BANG FUTURE TECH & LIFE CO., LTD Corporate Summary
Table 50. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 51. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Beaukev Pharma International Pvt.Ltd Corporate Summary
Table 53. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 54. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. DEAFARMA Corporate Summary
Table 56. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 57. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Tecoland Corporate Summary
Table 59. Tecoland Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 60. Tecoland Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Anhui HaiKang Pharmaceutical Co. Ltd Corporate Summary
Table 62. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 63. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Shanghai Haoyuan Chemexpress Co., Ltd Corporate Summary
Table 65. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 66. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Beijing Kawin Technology Share-holding Co Corporate Summary
Table 68. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 69. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Hangzhou Longshine Bio-Tech Co Corporate Summary
Table 71. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 72. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 74. Global Sofosbuvir (CAS 1190307-88-0) Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Sofosbuvir (CAS 1190307-88-0) Production by Region, 2017-2022 (MT)
Table 76. Global Sofosbuvir (CAS 1190307-88-0) Production by Region, 2023-2028 (MT)
Table 77. Sofosbuvir (CAS 1190307-88-0) Market Opportunities & Trends in Global Market
Table 78. Sofosbuvir (CAS 1190307-88-0) Market Drivers in Global Market
Table 79. Sofosbuvir (CAS 1190307-88-0) Market Restraints in Global Market
Table 80. Sofosbuvir (CAS 1190307-88-0) Raw Materials
Table 81. Sofosbuvir (CAS 1190307-88-0) Raw Materials Suppliers in Global Market
Table 82. Typical Sofosbuvir (CAS 1190307-88-0) Downstream
Table 83. Sofosbuvir (CAS 1190307-88-0) Downstream Clients in Global Market
Table 84. Sofosbuvir (CAS 1190307-88-0) Distributors and Sales Agents in Global Market
Table 1. Key Players of Sofosbuvir (CAS 1190307-88-0) in Global Market
Table 2. Top Sofosbuvir (CAS 1190307-88-0) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Companies, 2017-2022
Table 5. Global Sofosbuvir (CAS 1190307-88-0) Sales by Companies, (MT), 2017-2022
Table 6. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Sofosbuvir (CAS 1190307-88-0) Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Type
Table 9. List of Global Tier 1 Sofosbuvir (CAS 1190307-88-0) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sofosbuvir (CAS 1190307-88-0) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales (MT), 2017-2022
Table 15. By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales (MT), 2023-2028
Table 16. By Application – Global Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales (MT), 2017-2022
Table 20. By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales (MT), 2023-2028
Table 21. By Region – Global Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales (MT), 2017-2022
Table 25. By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales (MT), 2023-2028
Table 26. By Country - North America Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2017-2022
Table 29. By Country - North America Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2023-2028
Table 30. By Country - Europe Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2017-2022
Table 33. By Country - Europe Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2023-2028
Table 34. By Region - Asia Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2017-2022
Table 37. By Region - Asia Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2023-2028
Table 38. By Country - South America Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2017-2022
Table 41. By Country - South America Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales, (MT), 2023-2028
Table 46. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 47. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 48. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. DONG BANG FUTURE TECH & LIFE CO., LTD Corporate Summary
Table 50. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 51. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Beaukev Pharma International Pvt.Ltd Corporate Summary
Table 53. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 54. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. DEAFARMA Corporate Summary
Table 56. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 57. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Tecoland Corporate Summary
Table 59. Tecoland Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 60. Tecoland Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Anhui HaiKang Pharmaceutical Co. Ltd Corporate Summary
Table 62. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 63. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Shanghai Haoyuan Chemexpress Co., Ltd Corporate Summary
Table 65. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 66. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Beijing Kawin Technology Share-holding Co Corporate Summary
Table 68. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 69. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Hangzhou Longshine Bio-Tech Co Corporate Summary
Table 71. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product Offerings
Table 72. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 74. Global Sofosbuvir (CAS 1190307-88-0) Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Sofosbuvir (CAS 1190307-88-0) Production by Region, 2017-2022 (MT)
Table 76. Global Sofosbuvir (CAS 1190307-88-0) Production by Region, 2023-2028 (MT)
Table 77. Sofosbuvir (CAS 1190307-88-0) Market Opportunities & Trends in Global Market
Table 78. Sofosbuvir (CAS 1190307-88-0) Market Drivers in Global Market
Table 79. Sofosbuvir (CAS 1190307-88-0) Market Restraints in Global Market
Table 80. Sofosbuvir (CAS 1190307-88-0) Raw Materials
Table 81. Sofosbuvir (CAS 1190307-88-0) Raw Materials Suppliers in Global Market
Table 82. Typical Sofosbuvir (CAS 1190307-88-0) Downstream
Table 83. Sofosbuvir (CAS 1190307-88-0) Downstream Clients in Global Market
Table 84. Sofosbuvir (CAS 1190307-88-0) Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Sofosbuvir (CAS 1190307-88-0) Segment by Type
Figure 2. Sofosbuvir (CAS 1190307-88-0) Segment by Application
Figure 3. Global Sofosbuvir (CAS 1190307-88-0) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sofosbuvir (CAS 1190307-88-0) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2028 (US$, Mn)
Figure 7. Sofosbuvir (CAS 1190307-88-0) Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Sofosbuvir (CAS 1190307-88-0) Revenue in 2021
Figure 9. By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 10. By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Sofosbuvir (CAS 1190307-88-0) Price (USD/MT), 2017-2028
Figure 12. By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 13. By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Sofosbuvir (CAS 1190307-88-0) Price (USD/MT), 2017-2028
Figure 15. By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 16. By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 19. US Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 24. Germany Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 25. France Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 33. China Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 37. India Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 40. Brazil Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 44. Turkey Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Sofosbuvir (CAS 1190307-88-0) by Region, 2021 VS 2028
Figure 50. Sofosbuvir (CAS 1190307-88-0) Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Sofosbuvir (CAS 1190307-88-0) Segment by Type
Figure 2. Sofosbuvir (CAS 1190307-88-0) Segment by Application
Figure 3. Global Sofosbuvir (CAS 1190307-88-0) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sofosbuvir (CAS 1190307-88-0) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sofosbuvir (CAS 1190307-88-0) Revenue, 2017-2028 (US$, Mn)
Figure 7. Sofosbuvir (CAS 1190307-88-0) Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Sofosbuvir (CAS 1190307-88-0) Revenue in 2021
Figure 9. By Type - Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 10. By Type - Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Sofosbuvir (CAS 1190307-88-0) Price (USD/MT), 2017-2028
Figure 12. By Application - Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 13. By Application - Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Sofosbuvir (CAS 1190307-88-0) Price (USD/MT), 2017-2028
Figure 15. By Region - Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 16. By Region - Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 19. US Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 24. Germany Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 25. France Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 33. China Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 37. India Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 40. Brazil Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share, 2017-2028
Figure 44. Turkey Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Sofosbuvir (CAS 1190307-88-0) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Sofosbuvir (CAS 1190307-88-0) by Region, 2021 VS 2028
Figure 50. Sofosbuvir (CAS 1190307-88-0) Industry Value Chain
Figure 51. Marketing Channels
